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Abstract
Background: A clear picture of the mechanisms controlling glutamate receptor expression,
localization, and stability remains elusive, possibly due to an incomplete understanding of the
proteins involved. We screened transposon mutants generated by the ongoing Drosophila Gene
Disruption Project in an effort to identify the different types of genes required for glutamate
receptor cluster development.
Results:  To enrich for non-silent insertions with severe disruptions in glutamate receptor
clustering, we identified and focused on homozygous lethal mutants in a collection of 2185 BG and
KG transposon mutants generated by the BDGP Gene Disruption Project. 202 lethal mutant lines
were individually dissected to expose glutamatergic neuromuscular junctions, stained using
antibodies that recognize neuronal membrane and the glutamate receptor subunit GluRIIA, and
viewed using laser-scanning confocal microscopy. We identified 57 mutants with qualitative
differences in GluRIIA expression and/or localization. 84% of mutants showed loss of receptors
and/or clusters; 16% of mutants showed an increase in receptors. Insertion loci encode a variety
of protein types, including cytoskeleton proteins and regulators, kinases, phosphatases, ubiquitin
ligases, mucins, cell adhesion proteins, transporters, proteins controlling gene expression and
protein translation, and proteins of unknown/novel function. Expression pattern analyses and
complementation tests, however, suggest that any single mutant – even if a mutant gene is uniquely
tagged – must be interpreted with caution until the mutation is validated genetically and
phenotypically.
Conclusion: Our study identified 57 transposon mutants with qualitative differences in glutamate
receptor expression and localization. Despite transposon tagging of every insertion locus,
extensive validation is needed before one can have confidence in the role of any individual gene.
Alternatively, one can focus on the types of genes identified, rather than the identities of individual
genes. This genomic approach, which circumvents many technical caveats in favor of a wider
perspective, suggests that glutamate receptor cluster formation involves many cellular processes,
including: 1) cell adhesion and signaling, 2) extensive and relatively specific regulation of gene
expression and RNA, 3) the actin and microtubule cytoskeletons, and 4) many novel/unexplored
processes, such as those involving mucin/polycystin-like proteins and proteins of unknown function.
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Background
The vast majority of fast synaptic transmission in the
mammalian central nervous system is glutamatergic.
Proper expression, localization, and regulation of gluta-
mate receptors are critical for brain development and plas-
ticity. Not surprisingly, the molecular mechanisms
controlling glutamate receptor expression, localization,
and stability are of great interest. The most common
recent approach to understanding these mechanisms has
been biochemical: Proteins are identified based on a bio-
chemical interaction with a glutamate receptor subunit.
This approach has identified a number of important can-
didates, some of which have been subsequently shown to
play important roles in glutamate receptor trafficking and
stability at the PSD (for review see [1,2]).
An alternative approach is forward genetics: Mutant ani-
mals are screened for alterations in glutamate receptor
localization. Perhaps the most well-known glutamate
receptor trafficking protein identified via genetics is star-
gazin, which is disrupted in stargazer mutant mice [3].
The identification of stargazin was serendipitous; mam-
malian genetic screens are unfortunately still relatively
time-consuming and expensive (though this may change
as RNAi techniques advance). Most forward genetic
screens glutamate receptor mutants have used C. elegans.
Studies using C. elegans have highlighted the importance
of ubiquitination, CamKII, and PDZ proteins in control-
ling glutamate receptor number, and identified a novel
protein required for nematode glutamate receptor func-
tion [4-7]. Unfortunately, glutamatergic synapses in C. ele-
gans are accessible for electrophysiology only with great
difficulty. The subunit composition of C. elegans receptors
in vivo has also not yet been determined, which hinders
the study of subunit-specific trafficking mechanisms.
Drosophila are not only amenable to powerful genetics,
but also contain glutamatergic neuromuscular junctions
(NMJs) that are individually identifiable and accessible
throughout development to high-resolution electrophysi-
ological and microscopic techniques. These techniques
have revealed a significant amount of information con-
cerning this popular model synapse, including the exact
subunit composition of glutamate receptors in vivo. Dro-
sophila NMJs contain two subtypes of postsynaptic gluta-
mate receptor, which are molecularly, pharmacologically,
and spatially distinct [8-11]. The 'A' receptor subtype con-
tains the subunit GluRIIA, in combination with subunits
GluRIIC, GluRIID, and GluRIIE. The 'B' receptor subtype
contains the subunit GluRIIB, in combination with the
subunits GluRIIC, GluRIID, and GluRIIE. Both receptor
subtypes are most similar in sequence to mammalian kai-
nate receptors. The Drosophila genome also encodes recep-
tor subunits with high similarity to mammalian AMPA,
delta, and NMDA receptor subunits, but these proteins are
not found postsynaptically in the NMJ. Virtually nothing
is known about the molecular mechanisms that control
Drosophila  glutamate receptor expression, localization,
and stability.
To determine the molecular mechanisms controlling Dro-
sophila  glutamate receptor expression, localization, and
stability, we are screening transposon insertion mutants
generated by the Berkeley Drosophila  Gene Disruption
Project [12]. This mutant collection contains insertions in
over 40% of the entire genome, and the insertion site for
almost every mutant has already been identified by
inverse PCR. With the addition of transposon insertions
from other collections, it is likely that Drosophilists will
have access to insertion mutants of almost every gene in
the fly genome within a few years. Theoretically, one
could quickly and efficiently identify the complete list of
genes required for any particular process simply by exam-
ining a non-redundant set of mutants for a phenotype of
interest. We are testing this idea and using this approach
to define the broad categories of genes required for gluta-
mate receptor cluster formation. We identified 57 lethal
mutants with qualitatively abnormal glutamate receptor
clusters. Here, we present this list and discuss the types of
genes that are, and are not, represented. Because of the
high prevalence of background mutations even in trans-
poson mutant collections, the role of individual genes
must be extensively confirmed before a role for any partic-
ular protein is assumed. However, this problem may be
circumvented, and perhaps more insight gained, by focus-
ing on the types of genes identified rather than the iden-
tity of individual genes. We do so here.
Results
We sought to identify Drosophila mutants with abnormal
glutamate receptor cluster development. Elimination of
Drosophila  NMJ glutamate receptors results in paralysis
and embryonic lethality [9]. Mutations that reduce (but
do not eliminate) NMJ glutamate receptors allow hatch-
ing, but typically cause larval or pupal lethality [8-10].
Any effective screen for glutamate receptor cluster forma-
tion mutants must therefore include examination of
homozygous lethal mutants. However, proper examina-
tion of glutamate receptor clusters in embryos and larvae
requires technically challenging dissection techniques and
time-consuming confocal microscopy. Therefore, we
sought to minimize examination of mutants that do not
have glutamate receptor cluster defects. To do this, we
made the assumption, based on the studies cited above,
that mutants with severe defects in glutamate receptor
cluster formation are more likely to be homozygous
lethal. Thus, the first step in our screen for mutants with
reduced or eliminated glutamate receptors was identifica-
tion of recessive lethal transposon mutants (e.g. insertions
lines with no homozygous viable adults). WeBMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
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concentrated on the collection of GT1 and SuPor-P inser-
tion mutants, since these transposons were engineered for
maximal gene disruption [13,14]. Of 2185 mutants (rep-
resenting insertions in approximately 16% of the entire
genome), 220 insertion lines contained lethal mutations.
Because a prerequisite for NMJ glutamate cluster forma-
tion is development of neuromusculature, we examined
dechorionated embryos from each of the 220 stocks to
ensure that homozygous mutants developed into 'mor-
phologically mature' late stage embryos typical of
wildtype animals 16–17 hr after egg laying, AEL, which is
when NMJs begin to form [15-18]. Morphological matu-
rity was based on the presence of characteristics typical of
late stage 17: clear segmentation, mouthhooks, con-
densed CNS, malphigian tubules, and visible trachea. 205
of 220 (93%) of the homozygous lethal mutants formed
morphologically mature embryos. 202 of these mutants
were rebalanced using a GFP-tagged balancer chromo-
some for unambiguous identification of homozygous
mutant animals. We were unable to rebalance 3 mutant
lines using chromosome-appropriate GFP-tagged balanc-
ers, possibly because the insertion mutant chromosome
and balancer chromosome both contained lethal muta-
tions that fail to complement. We then verified that all
202 GFP-balanced stocks did indeed carry recessive lethal
mutations and determined the latest stage to which
homozygous (non GFP) embryos and larvae lived.
For each of the 202 balanced lines, several (typically 5–
10) homozygous mutant animals, along with control het-
erozygous siblings, were manually dissected at the latest
viable stage to expose NMJs on ventral longitudinal mus-
cles, then fixed and stained using anti-HRP antibodies
that recognize all neuronal membrane (including periph-
eral axons and NMJs) and anti-GluRIIA antibodies. After
dissection, fixation, and staining, each of the 202 rebal-
anced mutant lines was examined for changes in NMJ
morphology and glutamate receptor expression using
laser-scanning confocal fluorescent microscopy. 57 of the
202 rebalanced lethal mutants (28%) displayed consist-
ent (most NMJs in several animals) defects in glutamate
receptor expression without severe presynaptic morpho-
logical abnormalities (e.g. 57 mutants were identified in
which NMJs formed, but glutamate receptor clusters were
altered). Examples of some of these phenotypes, from
both embryonic and larval NMJs, are shown in Fig. 1.
All phenotypes could be classified into one of two broad
categories: 1) loss of glutamate receptors (fewer glutamate
receptor clusters or smaller individual clusters), or 2) gain
of glutamate receptors (more clusters or larger clusters).
We relied on cluster size and number because cluster size
and number measurements (compared to fluorescence
intensity measurements) avoid a requirement for fluores-
cence intensity calibration or problems associated with
potential differences in background immunofluorescence
between genotypes. Assuming constant receptor density,
cluster size should be directly proportional to the number
of clustered receptors. In support of this assumption,
immunoreactive cluster sizes correlate well with high-res-
olution patch-clamp electrophysiological measurements
between genotypes [11,19,20] and throughout embry-
onic/larval NMJ development (Featherstone, unpub-
lished observations).
Most (84%) of the mutants with disruptions in glutamate
receptor clusters showed a qualitative loss in receptors.
Severe loss of GluRIIA was always associated with embry-
onic/L1 lethality. One example is P{SUPor-P}KG00333,
which shows a complete loss of A-type receptors despite
the presence of morphologically normal presynaptic ter-
minals (Fig. 1A, left). Some mutants with loss of receptors
survived until pupation. An example of a third instar via-
ble mutant, P{SUPor-P} ChroKG03258, with reduced
GluRIIA is shown in Fig. 1B (middle column).
A minority (16%) of third instar viable mutants showed a
qualitative increase in GluRIIA immunoreactivity. An
example of one of these mutants, P{SUPor-P} vriKG01220, is
shown in Fig. 1B (right column). Except for P{SUPor-
P}KG00212, all of the mutants that displayed an increase
in GluRIIA immunoreactivity were viable as third instar
larvae and also displayed an increase in the number of
presynaptic boutons. This presynaptic phenotype is con-
sistent with previous Drosophila studies showing that over-
expression of postsynaptic GluRIIA causes presynaptic
overgrowth [21]. BG and KG transposons are designed to
generate loss of function mutations. Therefore, the isola-
tion of mutants with increased receptor cluster size sug-
gests that receptor insertion and clustering per se are not
rate-limiting. There are molecular mechanisms, revealed
by our screen, that actively restrain the number of synaptic
glutamate receptors.
For all of the mutants identified in our screen, the Gene
Disruption Project has precisely determined the genomic
insertion site of the transposon using inverse PCR. In the
vast majority of cases, inverse PCR results were consistent
with a unique insertion, and in most cases the flanking
genomic sequence revealed that the insertion was in an
annotated gene. For each of the mutants identified in our
screen, we used the BDGDP P-screen database http://fly
push.imgen.bcm.tmc.edu/pscreen/ and/or BLAST
searches with flanking genomic sequence from iPCR
results to identify which gene was mutated by the inserted
P-element. Putative functions were assigned to each of
these genes based on previous publications, FlyBase anno-
tations, and/or Genbank BLAST searches. We binned each
of the insertion site genes into one of the following func-
tional categories: 1) extracellular matrix proteinsBMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
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(mucins), 2) cell adhesion proteins 3) cytoskeleton pro-
teins, cytoskeletal regulators, and adaptor proteins, 4)
kinases and phosphatases, 5) ubiqitination proteins
(ubiquitin ligases), 6) transporters/pumps, 7) proteins
involved in gene expression and protein translation, 8)
enzymes, and 9) proteins of unknown/novel function.
These categories, and the relative number of proteins in
each category, are illustrated by Figure 2. All categories
shown in Figure 2 were represented by at least two mutant
genes.
Example phenotypes identified in the screen Figure 1
Example phenotypes identified in the screen. A: NMJs on embryonic ventral longitudinal muscles 7, 6, and 13, visualized 
using anti-HRP antibodies (which stain all neuronal membrane) and anti-GluRIIA antibodies (which stain postsynaptic glutamate 
receptors). HRP immunoreactivity is red; GluRIIA immunoreactivity is green. In wildtype NMJs (A, left column), GluRIIA immu-
noreactivity appears as puncta, representing clusters of postsynaptic glutamate receptors. In homozygous P{SUPor-P}KG00333 
mutants (A, right column), GluRIIA immunoreactivity is eliminated. B: NMJs on third instar larval longitudinal muscles 7 and 6, 
visualized using anti-HRP and anti-GluRIIA antibodies. In wildtype NMJs (B. left column), GluRIIA immunoreactivity appears as 
large blobs, representing developmentally merged puncta, at sites of innervation. In homozygous P{SUPor-P}Chro [KG03258] 
mutants (B, middle column), synaptic GluRIIA immunoreactivity is dramatically decreased, although extrasynaptic receptors 
remain prominent. In contrast, synaptic GluRIIA immunoreactivity is dramatically increased in homozygous P{SUPor-P}vri 
[KG01220] mutants (B, right column). Scale bars: 10 micrometers.BMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
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Table 1 contains the complete list of all mutants identified
in our screen, listed by functional category. For each
mutant, Table 1 indicates whether the phenotype was loss
(down arrow) or increase (up arrow) in postsynaptic
glutamate receptors. Table 1 also lists the Drosophila gene
in which each transposon is inserted, and the mouse
homolog of each of those genes (identified by BLASTP
against the mouse genome refseq protein database; http:/
/www.ncbi.nlm.nih.gov/genome/seq/MmBlast.html).
A definitive test of whether any particular gene is required
for glutamate receptor cluster development requires pre-
cise excision of each P-element insertion, or transgenic
rescue, followed by re-examination of the NMJ at the
same developmental stage – a task which is not practical
on a genomic scale. However, we performed two broad
types of checks to identify potential caveats in our results:
expression analysis and complementation tests for
lethality.
Pie chart showing the different types of proteins encoded by the insertion loci identified in the screen Figure 2
Pie chart showing the different types of proteins encoded by the insertion loci identified in the screen. The size 
of the pie wedge represents the proportion of genes of each type identified. Functional categories were based on previously 
published studies of the Drosophila gene and/or sequence similarity to functionally annotated mouse genes. Table 1 contains a 
complete list of the genes represented in this chart.BMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
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Table 1: Genes affected in glutamate receptor expression/localization mutants. Complete list of the mutants identified in the screen. 
Table 1 lists all of the mutants identified in the screen, organized by putative function of the protein encoded by the gene in which the 
transposon is inserted. The qualitative glutamate receptor phenotype in the Drosophila mutants is indicated by an arrow pointing 
upwards (for an increase in immunocytochemically detectable GluRIIA) or downwards (for a decrease in immunocytochemically 
detectable GluRIIA). The third column lists the Drosophila gene that is mutated by the transposon insertion; superscript letters 
represent complementation test results: 'f' = transposon insertion failed to complement a deficiency covering the region, and 'c' = 
insertion complemented a deficiency. Note that the confirmed presence of a background lethal mutation (denoted by 'c') does not 
indicate whether the NMJ phenotype is also complemented. The fourth column lists the mouse homolog, as determined by best 
BLAST match to an annotated gene in the mus musculus refseq database.
Allele Phenotype Mutant gene Mouse protein
Extracellular matrix
P{SUPor-P}CG18819 [KG01657] ↓ CG32814 mucin
P{SUPor-P}CG14713 [KG05924] ↓ CG14713 mucin
Cell adhesion
P{SUPor-P}mys [KG02930] ↓ mys beta integrin
P{SUPor-P}KG00212 ↑ Nrt neuroligin
Cytoskeleton, cytoskeletal regulators, and adaptor proteins
P{SUPor-P}CG10540 [KG02261] ↓ CG10540c actin capping protein
P{SUPor-P}KG01009 ↓ Tkr actinfilin
P{SUPor-P}pnut [KG00478] ↑ pnutf septin
P{SUPor-P}didum [KG04384] ↓ didumc myosin V
P{SUPor-P}neb [KG05913] ↓ nebf kinesin
P{SUPor-P}KG05547 ↓ Cdic dynein intermediate chain
P{SUPor-P}CG2095 [KG02723] ↓ CG2095f sec 8
P{SUPor-P}lap [KG06751] ↓ lap synaptosomal protein 91
P{SUPor-P}noodle [KG03815] ↓ CG3210 dynamin
Kinases & Phosphatases
P{SUPor-P}KG06341 ↓ KP78af MAP/MT affin.-reg. kinase
P{SUPor-P}SNF4Aγ  [KG00325] ↓ SNF4γ AMP-activated kinase
P{SUPor-P}trbl [KG02308] ↓ trbl AMP-activated kinase
P{SUPor-P}KG04591 ↑ CG15072c SNF-like kinase
P{SUPor-P}KG02006 ↓ Rheb RAS-homolog
P{SUPor-P}polo [16-1] ↓ polo polo-like kinase
P{SUPor-P}KG00853 ↓ CG10082c inositol hexaphosphate kin.
P{SUPor-P}CG32666 [KG03058] ↓ CG32666 serine-threonine kinase
P{SUPor-P}KG00564 ↓ ia2 rec. tyrosine phosphatase
P{SUPor-P}l(1)G0003 [KG02485] ↓ l(1)G003f Rab coupling protein
Ubiquitination
P{SUPor-P}Cbl [KG03080] ↓ Cbl E3 ubiquitin ligase
P{GT1}sina [BG02648] ↓ sina sina (ubiquitin ligase)
Transporters
P{SUPor-P}CG5802 [KG01634] ↑ CG5802f UDP-galactose translocator
P{SUPor-P}KG02272 ↓ CG8029f lysosomal H+ ATPase
P{SUPor-P}Vha44 [KG00915] ↓ Vha44 vacuolar H+ ATPase
Unknown
P{SUPor-P}oaf [KG03408] ↑ oafc D130038B21 RIKEN cDNA
P{SUPor-P}KG03591 ↓ CG32345 hyp. Protein XP_355833
P{SUPor-P}cmp44E [KG03925] ↓ cmp44Ec 'similar to KIAA0953'
P{SUPor-P}CG2185 [KG02712] ↑ CG2185 calcium binding P22
P{SUPor-P}KG00333 ↓ CG15358 cd209e antigen
P{SUPor-P}CG31694 [KG04350] ↑ CG31694f interferon development reg.
P{GT1}l(2)35Di [BG02008] ↓ l(2)35Dic [none]
P{SUPor-P}KG06339 ↓ [none]
Enzymes
P{SUPor-P}CG4825 [KG06018] ↓ CG4825 phosphatidylserine synth.
P{SUPor-P}TppII [KG03294] ↓ TppIIc tripeptidyl peptidase II
Gene expression & Translation
P{SUPor-P}KG02920 ↓ hsrω  f ladybird homeobox-1-like
P{SUPor-P}KG02514 ↓ hbn aristaless-rel. homeobox
P{SUPor-P}KG03852 ↓ Ntf-2 nuclear transport factor-2
P{SUPor-P}Trn-SR [KG04870] ↓ CG2848 transportin 3
P{GT1}CG10689 [BG01776] ↓ CG10689 DEAH box polypeptideBMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
Page 7 of 12
(page number not for citation purposes)
Drosophila glutamate receptors are expressed in neurons
and muscles. Thus, any gene required for expression and/
or localization of glutamate receptors should be expressed
in neurons and/or muscles. The Drosophila  gene
expression database (accessed at: http://www.fruitfly.org/
cgi-bin/ex/insitu.pl) describes expression patterns of
approximately 3300 different Drosophila genes (~24% of
the genome), as determined by embryonic in situ cDNA
hybridization [22]. Of these 3300 genes, which presuma-
bly represent a random 'sampling' of the genome, 2350
(71%) are expressed in the nervous system and/or body
wall muscles. The gene expression database contains data
for 28 (49%) of the genes identified in our study. 24
(86%) of these genes identified by our screen are
expressed in the nervous or muscular systems. 4 (14%) of
the genes identified in our screen are annotated as not
detectably expressed in the nervous or muscular systems.
Thus, most (86%) of the genes identified in our screen
have expression patterns consistent with the conclusion
that these genes are important for glutamate receptor clus-
ter development, but we did not identify neuronal and
muscle genes significantly above the level expected by a
random sampling of the genome – possibly because the
fraction of genes expressed in neurons and muscles (71%)
is quite high to begin with. There may also be cell non
autonomous roles for some genes with regard to receptor
expression and/or localization.
Although all of the mutants identified in our screens dis-
played a receptor phenotype, and all of the mutants con-
tain a unique P-element insertion, an important genetic
caveat is that the receptor phenotype may not actually be
caused by the transposon insertion. For example, the P-
element mobilizations that generated each of the P-ele-
ment alleles for the gene disruption project may have also
created second-site mutations in an unknown locus.
Spontaneous mutations can also be easily stabilized and
propagated in a stock carrying a balanced lethal mutant
chromosome such as those screened here. To estimate the
frequency of background mutations in this transposon
mutant collection, we performed complementation tests
to determine whether the P-element insertions failed to
complement lethal alleles of the same insertion locus. Of
the 57 mutants identified in our screen, 20 were tested for
complementation to deficiencies that remove the inser-
tion site. Ten (50%) of the complementation tests failed,
suggesting that lethality in half of the mutants may be
caused by a mutation other than the P-element insertion.
These results are consistent with those from a related
screen for presynaptic morphology mutants (Liebl FLW,
Werner KM, McCabe BD, Featherstone DE: A Genome-
Wide P-element screen for Drosophila synaptogenesis
mutants. Manuscript in preparation), which included com-
plementation tests to over 80 genes. Complementation
did not appear to be biased for any particular type of gene
(in this or the related Liebl et al study). We did not
P{SUPor-P}CG11107 [KG02727] ↓ CG11107 DEAH box polypeptide
P{SUPor-P}pnt [KG04968] ↓ pnt avian leukemia oncogene
P{SUPor-P}KG00625 ↓ CG18591 snrpE
P{SUPor-P}RpL3 [KG05440] ↓ RpL3f ribosomal protein L3
P{SUPor-P}KG03101 ↓ Ef2b translation elong. factor 2
P{SUPor-P}crp [KG00953] ↓ crp transcription factor AP-4
P{SUPor-P}E2f [KG03332] ↑ E2f E2f transcription factor
P{SUPor-P}armi [KG04664] ↓ armic Moloney leukemia virus 10
P{SUPor-P}vri [KG01220] ↑ vri interleukin3 reg. nuc. factor
P{SUPor-P}Kr-h1 [KG00354] ↓ Kr-h zinc finger protein
P{SUPor-P}Bgb [KG03779] ↓ Bgb core binding factor beta
P{SUPor-P}KG06256 ↓ Chroc Domino (histone deactyl.)
P{SUPor-P}Chro [KG03258] ↓ Chro Domino (histone deactyl.)
P{SUPor-P}EcR [KG04522] ↓ EcR nuclear receptor 1, group H
Table 1: Genes affected in glutamate receptor expression/localization mutants. Complete list of the mutants identified in the screen. 
Table 1 lists all of the mutants identified in the screen, organized by putative function of the protein encoded by the gene in which the 
transposon is inserted. The qualitative glutamate receptor phenotype in the Drosophila mutants is indicated by an arrow pointing 
upwards (for an increase in immunocytochemically detectable GluRIIA) or downwards (for a decrease in immunocytochemically 
detectable GluRIIA). The third column lists the Drosophila gene that is mutated by the transposon insertion; superscript letters 
represent complementation test results: 'f' = transposon insertion failed to complement a deficiency covering the region, and 'c' = 
insertion complemented a deficiency. Note that the confirmed presence of a background lethal mutation (denoted by 'c') does not 
indicate whether the NMJ phenotype is also complemented. The fourth column lists the mouse homolog, as determined by best 
BLAST match to an annotated gene in the mus musculus refseq database. (Continued)BMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
Page 8 of 12
(page number not for citation purposes)
systematically test for complementation of the receptor
cluster phenotypes.
Discussion
In an effort to identify new genes required for glutamate
receptor cluster development, we screened lethal transpo-
son insertion mutants for alterations in postsynaptic
glutamate receptor clusters. 202 lethal insertion lines, rep-
resenting insertions in ~1.4% of the genome, were manu-
ally dissected and glutamate receptor clusters were
examined using immunocytochemistry and confocal
microscopy. This screen identified 57 mutations in 56 dif-
ferent loci. Transposon mutageneses are becoming
increasingly popular, because a transposon insertion
simultaneously mutates and 'tags' a gene. An assumption
of all transposon mutagenesis (and subsequent screens) is
that the insertion locus is responsible for any observed
phenotype. Expression analysis showed that the expres-
sion pattern of insertion loci identified in our screen is
broadly consistent with that expected from genes involved
in glutamate receptor cluster development, but also not
compellingly different (86% vs. 71%) from that expected
from a random sampling of the genome. Furthermore,
complementation tests suggest that approximately one-
half of the lethality observed in our screen was not due to
disruption of the insertion locus. Thus, it is impossible to
definitively say which particular genes are important with-
out extensive validation of each candidate. And even with
extensive validation sufficient to confirm that a particular
locus is involved, it is difficult to know whether a gene's
role in receptor cluster formation is indirect with regard to
glutamate receptor cluster formation (i.e. whether a gene
product regulates another protein which in turn clusters
receptors). Nevertheless, one cannot discount our results
without also casting aside the fact that decades of forward
genetic screens have successfully identified many genes
critical for many different processes [23]. But how does
one decide which screen 'hits' to trust, and is there any
way to usefully interpret results of forward genetic
screens?
Should we exclude from consideration all mutants in
which lethality was complemented (and conversely accept
all mutants in which lethality failed to be comple-
mented)? This depends on the degree of coupling
between two different phenotypes: lethality and abnor-
mal glutamate receptor cluster development. To enrich for
mutants with receptor cluster defects, we examined only
homozygous lethal mutants, on the assumption that
GluRIIA cluster defects and lethality are strongly linked.
Indeed, all of the mutants showing severe loss of GluRIIA
were embryonic/first instar lethal. Nevertheless, this
assumption probably does not hold for all mutants. At the
time this screen was initiated, it was assumed that all Dro-
sophila  NMJ glutamate receptors contained the subunit
GluRIIA, and that the viability of GluRIIA null mutants
was due to substitution by the alternate subunit GluRIIB
[24]. Thus, the presence and localization of GluRIIA was
considered an accurate marker for all NMJ receptors. Sub-
sequently, we and others have determined that the Dro-
sophila NMJ contains two independently assembled and
localized subtypes of postsynaptic glutamate receptors: A-
type receptors, that contain the subunit GluRIIA (plus
GluRIIC, GluRIID, and GluRIIE, but not GluRIIB), and B-
type receptors, which contain the subunit GluRIIB (plus
GluRIIC, GluRIID, and GluRIIE, but not GluRIIA) [8-10].
GluRIIA therefore serves as a tag for only one-half to two-
thirds (depending on developmental stage; Featherstone,
unpublished) of fly NMJ glutamate receptors. Complete
elimination of A-type receptors does not result in lethality
[24,25]. Conversely, lethality can obviously be caused by
many defects other than loss of NMJ glutamate receptors.
Since viability and glutamate receptor cluster develop-
ment may be only loosely coupled, complementation
tests for lethality indicate relatively little about the relia-
bility with which our screen identified genes required for
proper glutamate receptor cluster formation (although
these complementation results do give important insights
into the properties of this mutant collection, and
transposon mutageneses in general). Similarly, the large
fraction of genes expressed in the neuromusculature
makes it difficult to judge, based on expression, whether
any particular gene has simply been randomly selected.
Thus, we are left with uncertainty regarding any particular
gene until that gene's role in synaptogenesis can be exten-
sively validated – a prospect that is not practical on a
genomic scale. However, the sequencing of several meta-
zoan genomes, along with the realization that the func-
tion of homologous proteins tends to be conserved across
genomes, opens the possibility of another approach, as
demonstrated in our study: 'functional category analysis.'
Functional category analysis involves screening a non-
redundant collection of mutants for the phenotype of
interest, assigning putative functions bioinformatically,
and categorizing the 'hits' by function. The goal of this
approach is not to generate a definitive list of individual
proteins involved in a process, but to gain insight into the
types and relative numbers of proteins required. All of the
categories shown in Figure 2, for example, are represented
by several mutants. Therefore, even with a 50% accuracy
rate (which would be a worst case estimate; the real accu-
racy is probably substantially higher – see below), the
gene function categories are likely to be correctly identi-
fied. Functional category analysis recognizes that not all
hits will be valid, that not all genes will play roles specific
to a particular process, and that many proteins are only
indirectly required. Functional category analysis reveals
unexplored areas of relevant biology and provides a broad
roadmap for further study. For example: instead ofBMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
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studying the individual genes identified in Table 1 (which
is arguably a hit-and-miss endeavor unlikely to shed
much global insight into the process), we plan to focus
research toward understanding how RNA regulation and
regulated translation are involved in glutamate receptor
cluster formation. Similarly, we are directing efforts
toward understanding the interactions of receptors with
the actin and microtubule-based cytoskeletons. Prelimi-
nary results suggest that this approach is insightful and
effective [20]; Liebl, Karr, & Featherstone, unpublished
observations).
What percentage of the genome is involved in glutamate
receptor cluster development? Our results allow this ques-
tion to be addressed (at least with regard to the Drosophila
NMJ). If glutamate receptor cluster development and
lethality are completely uncoupled, then our results imply
that approximately 28% (57/202) of the entire Drosophila
genome is required for glutamate receptor cluster devel-
opment. Depending on the percentage of insertions that
were too hypomorphic to show qualitatively detectable
phenotypes via immunocytochemistry, that percentage
could be higher. Glutamate receptor cluster formation
and lethality, however, are not unrelated phenotypes.
Therefore, 28% is likely to be a gross overestimate. Com-
plete loss of Drosophila NMJ glutamate receptors results in
paralysis and embryonic lethality [9], and mutations that
reduce (but do not eliminate) NMJ glutamate receptors
allow hatching, but typically cause larval or pupal
lethality [8-10]. In the present study, all severe loss of
function phenotypes were associated with embryonic/
early larval lethality. If all GluRIIA cluster mutants are
lethal, then mutants with normal glutamate receptor clus-
ters would have been eliminated in the selection for
lethality early in the screen (indeed, this was the rationale
for this step). In this case, our results suggest that approx-
imately 2.6% (57/2185) of the genome is required for
glutamate receptor cluster formation. This estimate, how-
ever, is also likely to be flawed; although severe disrup-
tions in glutamate receptor cluster formation cause
lethality, not all lethality is likely due to disruptions in
glutamate receptor cluster formation. Mutations that trig-
ger loss of GluRIIA are not necessarily lethal [24,25].
Lethality and GluRIIA cluster phenotypes are not abso-
lutely coupled, and therefore 2.6% is likely too low of an
estimate.
Given the uncertainties above, we can say only that some-
where between 2.6 and 28% of the fly genome (360–3900
genes) is required for NMJ glutamate receptor cluster for-
mation. This is a wide range, which in any case represents
a surprisingly large number of genes. Is this reasonable?
Do all of these genes represent specific machinery for
glutamate receptor cluster expression and clustering? To
answer these questions, it is helpful to consider the types
of genes identified in the screen. As noted earlier, the role
of each individual gene needs to be validated before plac-
ing too much emphasis on any particular protein's role.
But a general discussion of the genes implicated is helpful
for evaluation of the general results.
In support of the idea that our screen correctly identified
genes required for glutamate receptor cluster formation,
some of the types of genes identified in our screen have
been previously identified as important for postsynaptic
development. Polo, for example, was identified in our
screen, and mammalian polo-like kinases are receiving
increasing attention as important players in synapse
development [26]. We also identified several other
kinases and phosphatases. Activation of the mitogen acti-
vated protein kinase (MAPK) pathway facilitates AMPAR
surface expression [27,28], and interaction of AMPAR
GluR2 subunits with GRIP and PICK1 is dependent upon
the phosphorylation of the GluR2 subunit [29,30]. Our
screen also isolated mutants in two different ubiquitin
ligases. Consistent with this, ubiquitination is known to
regulate glutamate receptor number and synapse develop-
ment [6,31]. Our screen identified a fly neuroligin family
member, and mammalian neuroligins were recently
implicated in postsynaptic development [32].
One of the largest groups of genes identified in our screen
encodes proteins that comprise or regulate the actin and/
or microtubule cytoskeletons. Glutamate receptors, like
many other proteins, are thought to be transported along
microtubules, and anchored to the synaptic actin cytoskel-
eton [33-35]. In support of this, we've recently found that
GluRIIA-containing receptors are specifically linked to the
actin cytoskeleton via the 4.1 homolog coracle, which
interacts directly with GluRIIA [20]. We've also found that
regulation of synaptic microtubules affects fly NMJ gluta-
mate receptor cluster development (see below). The
cytoskeleton might not only be important for receptor
protein localization; trafficking and localization of syn-
apse-specific mRNAs (see below) probably also relies on
the cytoskeleton. Consistent with this, untranslated
regions of GluRIIA appear to be required for proper syn-
aptic receptor localization in the fly NMJ (Karr & Feather-
stone, unpublished).
Other types of genes identified by the screen are consistent
with what one might expect. For example, many of the
genes identified in our screen are involved in gene expres-
sion or protein translation. Mutation of a transcription
factor or component of the translation machinery would
be expected to disrupt many downstream things, includ-
ing production of the cellular machinery required for
postsynaptic development. Since our screen specifically
excluded mutants which did not develop to the later
stages of embryogenesis, and which did not formBMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
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neuromuscular junctions, our screen may have high-
lighted components of pathways specific for a subset of
cell differentiation steps that includes glutamate receptor
cluster formation. Some of this machinery is possibly
localized to the synapse. Drosophila  GluRIIA mRNA is
localized to the NMJ and locally translated [36]. Mamma-
lian glutamate receptors may also rely on local translation
and editing for surface expression [37-39]. Preliminary
results also suggest that Drosophila NMJ glutamate recep-
tor cluster formation depends on a burst of receptor sub-
unit transcription that follows contact between pre and
postsynaptice cells (Karr & Featherstone, unpublished).
Our screen also revealed some important surprises. For
example, we identified insertions in two different putative
mucin-encoding genes. Mammalian mucins are secreted
glycoproteins that are widely implicated in tumor cell
adhesion but have no previously identified role in the
nervous system [40]. Are these false positives or important
insights into postsynaptic development? Interestingly, the
'mucin' genes identified in our screen are also similar to
the C. elegans polycystin gene lov-1, which is localized to
the ciliated sensory endings of dendrites required for male
mating behavior, where it may be critical for regulating
localization of other transmembrane proteins [41,42].
Our screen also identified the exocyst protein sec-8. Sec-8
has recently been implicated in NMDA receptor traffick-
ing but has not been shown to regulate non-NMDA recep-
tor localization, and the mechanism by which it (and
other sec proteins) functions remains unclear [43,44]. We
are particularly interested in validating and studying the
most surprising candidates from out screen, and have
done so for sec 8. This work (Liebl FLW, Chen K, Karr J,
Sheng Q, Featherstone DE: Altered Synapse Develop-
ment in Drosophila Sec 8 Mutants. Manuscript in prepara-
tion, and Liebl & Featherstone, unpublished) reveals that
Drosophila  sec 8 regulates the synaptic microtubule
cytoskeleton to facilitate transmembrane protein localiza-
tion (Thus the inclusion of sec 8 as a 'cytoskeletal regula-
tor' in Table 1). Thus, even the surprises identified by our
screen are, so far, apparently reasonable. But note that
even validated candidates, such as sec 8, may not work
directly or specifically on glutamate receptors.
Approximately 12% of the genes identified in our screen
encode proteins with unknown or novel function. A better
understanding of these genes is important for understand-
ing both those protein families and synaptogenesis –
assuming these proteins are really regulators of receptor
cluster formation. Even with a 50% success rate in identi-
fying genes involved in receptor cluster formation – and
the arguments and data above suggest the success rate was
much higher – it is clear that novel genes encode a large
fraction of proteins required for glutamate receptor cluster
development in the fly NMJ. Therefore, major unexplored
areas apparently may exist with regard to postsynaptic
development. Interestingly, our screen did not isolate any
PDZ-domain or MAGUK proteins, which are widely
regarded as essential trafficking and scaffold proteins at
mammalian glutamatergic synapses [45]. However, this
may not reflect a complete lack of importance for these
proteins in fly NMJ glutamate receptor localization. Dro-
sophila discs-large (DLG) is the sole fly representative of
the mammalian DLG/SAP 97/SAP102/PSD-95 protein
family; DLG is important for formation of fly NMJ gluta-
mate receptor clusters that contain the subunit GluRIIB,
but not those containing GluRIIA [11]. Because we
screened only for alterations in GluRIIA immunoreactiv-
ity, we would not have isolated DLG mutants. However,
our results do support the idea that PDZ proteins are not
predominant components of the glutamate receptor local-
ization/stabilization machinery in Drosophila NMJs.
Many of the genes implicated by our screen probably do
not work directly or specifically. Kinases only have to reg-
ulate something that in turn regulates receptor cluster for-
mation. Transcription and translation factors probably
control expression of multiple proteins required for PSD
formation. Given the fact that many proteins definitively
required for glutamate receptor cluster formation may not
work directly, it is reasonable that a large percentage of the
genome appears to be required. In other words, it is not
difficult to identify proteins required for receptor cluster
development, and we feel that the demonstration of such
by itself does not give real insight into receptor cluster for-
mation. An alternative approach, which we call 'func-
tional category analysis' and introduce here, is to focus on
the types of genes identified rather than the identities of
individual genes, in an effort to gain larger insights into
the entire process. Subsequent work can then be directed
at investigating the processes represented by these gene
types, rather than validation of individual genes that may
or may not work directly or be applicable to other syn-
apses and organisms. For example, many microtubule and
actin regulators were identified in our screen. The target
for these proteins, obviously, is likely to be cytoskeletal
proteins instead of receptors. But their identification tells
which types of cytoskeleton might be important for gluta-
mate receptor cluster formation. Using these clues, we
subsequently determined that microtubules are important
for fly glutamate receptor trafficking (Liebl FLW, Chen K,
Karr J, Sheng Q, Featherstone DE: Altered Synapse Devel-
opment in Drosophila Sec 8 Mutants. Manuscript in prep-
aration, and Liebl & Featherstone, unpublished), and that
A-type receptors are anchored via the 4.1 protein coracle
to postsynaptic actin [20].
Conclusion
We identified 57 transposon mutants with qualitative dif-
ferences in glutamate receptor expression andBMC Neuroscience 2005, 6:44 http://www.biomedcentral.com/1471-2202/6/44
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localization. Mutant gene identities need to be validated
despite the fact that mutant genes are tagged. Focus on the
types of genes identified ('functional category analysis')
may provide more useful insight into the process of gluta-
mate receptor cluster formation, compared to focus on
individual genes. Our results suggest that glutamate recep-
tor cluster formation involves cell adhesion and signaling,
extensive and relatively specific regulation of gene expres-
sion and RNA regulation, the actin and microtubule
cytoskeletons, and many novel/unexplored processes
such as those involving mucin/polycystin-like proteins
and proteins of unknown function.
Methods
NMJ staining and microscopy was performed as previ-
ously described [9,19]. Briefly, animals were dissected and
fixed for 30–60 min in Bouin's fixative. Late stage
embryos were dechorionated in bleach and then manu-
ally devitellinated and dissected. Mouse monoclonal anti-
GluRIIA ('8B4D2' Iowa Developmental Studies Hybrid-
oma Bank, Iowa City, IA) was used at 1:100. Fluorescently
conjugated anti-HRP (Jackson Immunoresearch Labs,
West Grove, PA) was used at 1:100. Goat anti-rabbit or
goat anti-mouse fluorescent (FITC or TRITC) secondary
antibodies (Jackson Immunoresearch Labs, West Grove,
PA) were used at 1:400. Confocal images were obtained
using an Olympus FV500 laser-scanning confocal micro-
scope. Image analysis and quantification was performed
using ImageJ software.
Complementation analysis was performed by crossing
GFP-balanced  P-element mutant stocks to a balanced
stock containing a deficiency that removes the insertion
site. The F1 generation of each cross was examined for the
presence or absence of adult flies carrying neither balancer
chromosome. Thus, P-element insertion chromosomes
were tested for their capacity to complement the viability
of the lethal mutations in the gene carrying the P-element
insertion.
All P-element stocks were obtained from Bloomington
Stock Center flystocks.bio.indiana.edu. 'Control' geno-
types in all experiments are w1118.
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